Abstract
Power Doppler (PD) is a recent color- Doppler Ultrasound (US)-technique, which allows to detect the presence of flow even in very small vessels, providing a sort of angiographic micromap. The aim of this study was to evaluate whether percutaneous ethanol injection (PEI) outcome might be improved by injecting the ethanol into the nodule under PD assistance. Thus, 14 patients affected with pretoxic (PTA) and 8 with toxic adenoma (TA) were submitted to this alternative tool. Before PEI, all patients were submitted to a careful endocrinological study, including an US-guided fine-needle biopsy in order to exclude the presence of malignancy. In addition, all the nodules were evaluated at PD-US and their vascular patterns were recorded on videotape and compared with those obtained after treatment. The procedure consisted of slow injection of sterile ethanol under direct PD-US control. The number of PEI sessions was 2.3±0.1 in PTA and 3.0±0.3 in TA. All patients were also evaluated 3, 6, 12 and 18 months after PEI. Successful therapy was considered when normalization of thyroid hormones and TSH was achieved together with the disappearance of nodular hyperactivity and complete recovery of extra-nodular tracer uptake at scintigraphy. PEI was tolerated very well by all patients. The most common side effect was a transient local or irradiated pain. All patients with PTA and 6 out of 8 patients with TA were successfully treated. In these cases, PD-US showed the progressive reduction of the intranodular blood flow, up to its extinction after 6-12 months, with the presence of little perilesional vascular spots. Nodular shrinkage was obtained in all patients (from 4.7±0.7 to 1.1±0.4 ml in PTA and from 21.0±2.8 to 6.2±1.6 ml in TA). In conclusion, PD assistance improves PEI procedure, since it allows to guide the ethanol injection towards the principal afferent vessels of the nodules and to monitor the diffusion and the effects of ethanol on nodular vascularization.
Similar content being viewed by others
References
Livraghi T., Paracchi A., Ferrari C., Bergonzi M., Garavaglia G., Raineri P., Vettori C. Treatment of autonomous thyroid nodules with percutaneous ethanol injection: preliminary results. Radiology 1990, 175: 827–829.
Hamburger J.I. The autonomously functioning thyroid nodule: Goetsch’s disease. Endocr. Rev., 1987, 8: 439–447.
O’Brien T., Gharib H., Suman V.J., van Heerden J. Treatment of toxic solitary thyroid nodules: surgery versus radioactive iodine. Surgery 1992, 112: 1166–1170.
Wagner H.E., Seiler C. Recurrent laryngeal nerve palsy after thyroid gland surgery. Br. J. Surg. 1994, 81: 226–228.
Jatzko G.R., Lisborg P.H., Muller M.G., Wette V.M. Recurrent nerve palsy after thyroid operations-principal nerve identification and literature review. Surgery 1994, 115: 139–144.
Bockish A., Jamitzky T., Derwanz R., Biersack H.J. Optimized dose planning of radioiodine therapy of benign thyroidal diseases. J. Nucl. Med. 1993, 34: 1632–1637.
Holm L.-E., Lundell G., Israelsson A., Dahlqvist I. Incidence of hypothyroidism occurring after iodine- 131 therapy for hyperthyroidism. J. Nucl. Med. 1982, 23: 103–107.
Huysmans D.A., Corstens F.H., Kloppenborg P.W. Long-term follow-up in toxic solitary autonomous thyroid nodules treated with radioactive iodine. J. Nucl. Med. 1991, 32: 27–30.
Clerc J., Dagousset F., Izembart M., Jais J.P., Heshmati H.M., Alcais A., Chevalier A., Leger A.F., Barritault L. Radioiodine treatment of the autonomous thyroid nodule in patients with or without visible extra nodular activity. J. Nucl. Med. 1995, 36: 217–223.
Bennedbaek F.N., Karstrup S., Hegedüs L. Percutaneous ethanol injection therapy in the treatment of thyroid and parathyroid diseases. Eur. J. Endocrinol. 1997, 136: 240–250.
Monzani F., Goletti O., Caraccio N., Del Guerra P., Ferdeghini M., Pucci E., Baschieri L. Percutaneous ethanol injection treatment of autonomous thyroid adenoma: hormonal and clinical evaluation. Clin. Endocrinol. (Oxf.) 1992, 36: 491–497.
Papini E., Panunzi C., Pacella C.M., Bizzarri G., Fabbrini R., Petrucci L., Pisicchio G., Nardi F. Percutaneous ultrasound-guided ethanol injection: a new treatment of toxic autonomously functioning thyroid nodules? J. Clin. Endocrinol. Metab. 1993, 76: 411–416.
Livraghi T., Paracchi A., Ferrari C., Reschini E., Macchi R.M., Bonifacino A. Treatment of autonomous thyroid nodules by percutaneous ethanol injection: 4-year experience. Radiology 1994, 190: 529–534.
Goletti O., Monzani F., Caraccio N., Del Guerra P., Lippolis P.V., Pucciarelli M., Seccia M., Carmassi F., Cavina E., Baschieri L. Percutaneous ethanol injection treatment of autonomously functioning single thyroid nodules: optimization of treatment and short term outcome. World J. Surg. 1992, 16: 784–790.
Paracchi A., Ferrari C., Livraghi T., Reschini E., Macchi R.M., Bergonzi M., Raineri P. Percutaneous intranodular ethanol injection: a new treatment for autonomous thyroid adenoma. J. Endocrinol. Invest. 1992, 15: 353–362.
Martino E., Multas M.L., Loviselli A., Piga M., Petrini L., Miccoli P., Pacini F. Percutaneous intranodular ethanol injection for treatment of autonomously functioning thyroid nodules. Surgery 1992, 112: 1161–1165.
Mazzeo S., Toni M.G., De Gaudio C., Caramella D., Pinto F., Lencioni R., Sanguinetti F., Bartolozzi C. Percutaneous injection of ethanol to treat autonomous thyroid nodules. Am. J. Roentgenol. 1993, 161: 871–876.
Özdemir H., Ilgit E.T., Yucel C., Atilla S., Isik S., Cakir N., Gokcora N. Treatment of autonomous thyroid nodules: safety and efficacy of sonographically guided percutaneous injection of ethanol. Am. J. Roentgenol. 1994, 163: 929–932.
Di Lelio A., Rivolta M., Casati M., Capra M. Treatment of autonomous thyroid nodules. Value of percutaneous ethanol injection. Am. J. Roentgenol. 1995, 164: 207–213.
Pacella C.M., Papini E., Bizzarri G., Fabbrini R., Anelli V., Rinaldi R. Assessment of the effect of percutaneous ethanol injection in autonomously functioning thyroid nodules by colour-coded duplex sonography. Eur. J. Radiol. 1995, 5: 395–400.
Monzani F., Caraccio N., Goletti O., Lippolis P.V., Casolaro A., Del Guerra P., Cavina E., Miccoli P. Five-year follow-up of percutaneous ethanol injection for the treatment of hyperfunctioning thyroid nodules: a study of 117 patients. Clin. Endocrinol. (Oxf.) 1997, 46: 9–15.
Spiezia S., Colao A., Assanti A.P., Cerbone G., Picone G.M., Merola B., Lombardi G. Utilità dell’eco color-doppler con power-doppler nella diagnostica dei noduli tiroidei ipoecogeni: work in progress. Radiol. Med. 1996, 91: 616–621.
Hegedus L., Karstrup S. Ultrasonography in the evaluation of cold thyroid nodules. Eur. J. Endocrinol. 1998, 138: 30–31.
Vitti P., Martino E., Aghini-Lombardi F., Rago T,, Antonangeli L,, Maccherini D., Nanni P., Loviselli A., Balestrieri A., Araneo G. Thyroid volume measurement by ultrasound in children as a tool for the assessment of mild iodine deficiency. J. Clin. Endocrinol. Metab. 1994, 79: 600–603.
Spiezia S., Cerbone G., Colao A., Assanti A.P., Picone G.M., Lombardi G. Usefulness of Power Doppler in the diagnostic management of hypoechoic thyroid nodules. Eur. J. Ultrasound 1997, 6 (3): 165–170.
Livraghi T., Giorgio A., Marin G., Salmi A., de Sio I., Bolondi L., Pompili M., Brunello F., Lazzaroni S., Torzilli G. Hepatocellular carcinoma and cirrhosis in 746 patients: long term result of percutaneous ethanol injection. Radiology 1995, 197: 101–108.
Spiezia S., Vallone P., Fiore F., Ricchi P., Daniele B., Picone G., Cerbone G., De Vivo R., Perrone F., Castiglione F., Pignata S. Power Doppler sonography to evaluate response to percutaneous ethanol injection in hepatocellular carcinoma. Ital. J. Gastroenterol. Hepatol. 1997, 29: 548–553.
Lippi F., Ferrari C., Manetti L., Rago T., Santini F., Monzani F., Bellitti P., Papini E., Busnardo B., Angelini F., Pinchera A., the multicenter study group. Treatment of solitary autonomous thyroid nodules by percutaneous ethanol injection: results of an italian multicenter study. J. Clin. Endocrinol. Metab. 1996, 81: 3261–3264.
Braun B., Blank W. Color Doppler sonography-guided percutaneous alcohol instillation in the therapy of functionally autonomous thyroid nodules. Dtsch. Med. Wochenschr. 1994, 119: 1607–1612.
Becker D., Bair H.J., Becker W., Gunter E., Lohner W., Lerch S., Hahn E.G. Thyroid autonomy with color-coded image-directed Doppler sonography: internal hypervascularization for the recognition of autonomous adenomas. J. Clin. Ultrasound 1997, 25: 63–69.
Dymling S.O., Persson H.W., Hertz C.H. Measurement in blood perfusion in tissue using Doppler ultrasound. Ultrasound Med. Biol. 1991, 17: 433–434.
Crescenzi A,. Papini E., Pacella C.M., Rinaldi R., Panunzi C., Petrucci L., Fabbrini R., Bizzarri G.C., Anelli V., Nardi F., Marinozzi V. Morphological changes in a hyperfunctioning thyroid adenoma after percutaneous ethanol injection: histological, enzymatic and sub-microscopical alterations. J. Endocrinol. Invest. 1996, 19: 371–376.
Ferrari C. Value of ethanol injection in the treatment of the autonomous thyroid nodule. J. Endocrinol. Invest. 1995, 18: 465–467.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cerbone, G., Spiezia, S., Colao, A. et al. Percutaneous ethanol injection under Power Doppler ultrasound assistance in the treatment of autonomously functioning thyroid nodules. J Endocrinol Invest 22, 752–759 (1999). https://doi.org/10.1007/BF03343640
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03343640